Hap Trading, LLC Fibrogen Inc Put Options Transaction History

Hap Trading, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 11, 2023	BUY	$2.49 - $20.59 $39,840 - $329,440	16,000 New	16,000 $43,000
Q2 2019 Aug 14, 2019	SELL	$35.13 - $55.53 $1.23 Million - $1.94 Million	-35,000 Reduced 70.0%	15,000 $43,000
Q1 2019 May 10, 2019	BUY	$42.83 - $59.91 $1.09 Million - $1.53 Million	25,500 Added 104.08%	50,000 $41,000
Q1 2018 May 11, 2018	BUY	$45.35 - $61.65 $1.11 Million - $1.51 Million	24,500 New	24,500 $77,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.